Improving diabetes care starts with funding research for novel and innovative approaches that help patients manage their health and ultimately achieve better health outcomes. PSDCF supports academic studies to investigate the effectiveness of medicines, devices, and care models. From promoting translational pharmacology that reduces adverse drug events, to funding population-specific behavioral research that encourages healthier living, we are excited to play a role in improving diabetes care for all.
Plant-derived cannabinoids, which are not toxic and devoid of psychoactive effects, may represent an effective new strategy in diabetes care. For patients with diabetes, managing their health is a struggle that can result in both acute hospitalizations due to hypoglycemia and the development of symptomless long-term complications due to prolonged poor care.
The Canebosem Project is dedicated to researching cannabinoids and their role in improving the daily management of diabetes and prevention of its complications. We engage in translational cannabinoid research with in-vivo patients as an initial step in innovation towards further understanding the therapeutic value of cannabinoids in both managing diabetes, and preventing the onset of long-term complications like cancer, glaucoma, and lower extremity amputation.
The Canebosem Project seeks to understand the science of cannabinoids and its role in resolving the racial and ethnic health disparities seen in patients with diabetes. Many patients struggle with diabetes because care is generic, costly, and largely ineffective. PSDCF believes that cannabinoids can play an important role as a cost-effective tool in personalized care plans for patients struggling with diabetes.
Learn more about the Canebosem Project.